Results 51 to 60 of about 70,191 (302)

Accessory Right Hepatic Artery Pseudoaneurysm Resulting in Biliary Obstruction

open access: yesCase Reports in Gastroenterology, 2023
Introduction: Visceral pseudoaneurysms are prone to rupture and can cause mass effect on surrounding structures, with extrinsic compression on the biliary tree being a rare but challenging complication.
Colin William Primrose, Nikolas Arestis
doaj   +1 more source

Autoimmune Comorbidities as Modifiers of Phenotypic Heterogeneity in Facioscapulohumeral Dystrophy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral dystrophy type 1 (FSHD1) shows clinical heterogeneity that is only partly explained by D4Z4 repeat unit (RU) size. Although immune and inflammatory mechanisms may contribute to disease variability, the prevalence and clinical impact of autoimmune diseases in FSHD remain unclear.
Jonathan Pini   +9 more
wiley   +1 more source

Cholangitis Lenta [PDF]

open access: yes, 2017
Cholangitis lenta, also known as ductular cholestasis, cholangiolar cholestasis, or subacute nonsuppurative cholangitis, is an uncommon type of cholangitis characterized by ductular reaction with inspissated bile in dilated ductules.
A. Laura De La Cruz   +7 more
core   +1 more source

A Scoping Review and Meta‐Analysis of Proportions of Central Nervous System Manifestations Reported in Patients with Sjögren's Disease

open access: yesArthritis Care &Research, Accepted Article.
Objective The objective of this scoping review was to synthesize evidence on the proportion of individuals living with Sjögren's disease who experience central nervous system (CNS) manifestations. Methods We searched MEDLINE (via PubMed) and Embase from 1980 through January 29, 2026, and the ECRI Guidelines Trust from 2020 through January 29, 2026 ...
Arun Varadhachary   +21 more
wiley   +1 more source

Peculiarities of clinical manifestations of opisthorchosis papillitis

open access: yesВестник хирургии имени И.И. Грекова, 2017
OBJECTIVE. The study identified peculiarities of clinical manifestations of opisthorchosis papillitis depending on the stage of disease. MATERIAL AND METHODS.
S. V. Onishchenko, V. V. Darvin
doaj   +1 more source

Pediatric Xanthogranulomatus cholangitis [PDF]

open access: yes, 2018
The Xanthogranulomatous cholangitis is rare entity, usually it happens as an extension of Xanthogranuloma of the gall bladder (XCC) [1], although they are case reports of isolated Xanthogranulomatous cholangitis in adult age group [2] [3], To best of our
Pawel T. Schubert   +5 more
core   +1 more source

acute cholangitis

open access: yes, 2022
raw data of acute cholangitis ...
Rock Bum Kim
core   +1 more source

Rab1A Promotes Hepatic Steatosis by Suppressing Mitophagy via the Raf‐1/ERK1/2/PINK1 Signaling Axis

open access: yesAdvanced Science, EarlyView.
Why does fat accumulate in the liver? Our study reveals Rab1A as the molecular switch that silences the cell's mitochondrial cleanup crew. Turning Rab1A off reactivates mitophagy, clears excess fat, and reverses fatty liver disease in mice—offering a promising new therapeutic target for MASLD, a growing global health challenge.
Li Zhang   +9 more
wiley   +1 more source

Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: Results of a 25-year follow-up study [PDF]

open access: yes, 2003
AIM: IBD is a systemic disease associated with a large number of extraintestinal manifestations (EIMs). Our aim was to determine the prevalence of EIMs in a large IBD cohort in Veszprem Province in a 25-year follow-up study.
Dávid, Gyula   +6 more
core   +1 more source

Primary biliary cholangitis: symptoms, diagnosis and treatment

open access: yes, 2017
Primary biliary cholangitis (PBC), previously known as primary biliary cirrhosis, is a chronic but progressive disease that, over many years, causes damage to bile ducts, leading to cholestasis and, in some patients, cirrhosis.
Gerri Mortimore, Mortimore, Gerri
core   +1 more source

Home - About - Disclaimer - Privacy